Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables … Read more
Aurora Cannabis Inc (ACB) - Net Assets
Latest net assets as of December 2025: $567.83 Million USD
Based on the latest financial reports, Aurora Cannabis Inc (ACB) has net assets worth $567.83 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($775.29 Million) and total liabilities ($207.47 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $567.83 Million |
| % of Total Assets | 73.24% |
| Annual Growth Rate | 38.67% |
| 5-Year Change | -70.27% |
| 10-Year Change | 10444.91% |
| Growth Volatility | 855.05 |
Aurora Cannabis Inc - Net Assets Trend (2007–2025)
This chart illustrates how Aurora Cannabis Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Aurora Cannabis Inc (2007–2025)
The table below shows the annual net assets of Aurora Cannabis Inc from 2007 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $605.09 Million | +0.36% |
| 2024-03-31 | $602.92 Million | +15.56% |
| 2023-03-31 | $521.74 Million | 0.00% |
| 2022-03-31 | $521.74 Million | -74.36% |
| 2021-03-31 | $2.04 Billion | -3.74% |
| 2020-03-31 | $2.11 Billion | -51.99% |
| 2019-03-31 | $4.40 Billion | +181.67% |
| 2018-03-31 | $1.56 Billion | +611.66% |
| 2017-03-31 | $219.71 Million | +3728.85% |
| 2016-03-31 | $5.74 Million | +49.71% |
| 2015-03-31 | $3.83 Million | +182.05% |
| 2014-03-31 | $1.36 Million | +96.85% |
| 2013-03-31 | $690.35K | -36.08% |
| 2012-03-31 | $1.08 Million | -21.40% |
| 2011-03-31 | $1.37 Million | -19.72% |
| 2010-03-31 | $1.71 Million | +5.92% |
| 2009-03-31 | $1.62 Million | -3.97% |
| 2008-03-31 | $1.68 Million | 0.00% |
| 2007-03-31 | $1.68 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Aurora Cannabis Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 633097701800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $6.95 Billion | 1232.64% |
| Other Comprehensive Income | $-55.91 Million | -9.92% |
| Total Equity | $563.91 Million | 100.00% |
Aurora Cannabis Inc Competitors by Market Cap
The table below lists competitors of Aurora Cannabis Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Phoenix Pioneer technology Co., Ltd.
TWO:6920
|
$199.16 Million |
|
Zhongxing Shenyang Commercial Building Group Co Ltd
SHE:000715
|
$199.18 Million |
|
Jinling Hotel Corp Ltd
SHG:601007
|
$199.20 Million |
|
Guangdong Redwall New Materials Co Ltd
SHE:002809
|
$199.22 Million |
|
BTB Real Estate Investment Trust
PINK:BTBIF
|
$199.14 Million |
|
Incar Financial Service Co. Ltd.
KQ:211050
|
$199.04 Million |
|
Zhejiang Int'L Group Co Ltd
SHE:000411
|
$199.04 Million |
|
Fraser and Neave Limited
PINK:FNEVF
|
$198.99 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aurora Cannabis Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 560,749,681 to 563,911,753, a change of 3,162,072 (0.6%).
- Net income of 1,591,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 12,131,569.
- Other factors increased equity by 13,702,641.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.59 Million | +0.28% |
| Other Comprehensive Income | $-12.13 Million | -2.15% |
| Other Changes | $13.70 Million | +2.43% |
| Total Change | $- | 0.56% |
Book Value vs Market Value Analysis
This analysis compares Aurora Cannabis Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.35x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.03x to 0.35x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-03-31 | $103.34 | $3.53 | x |
| 2008-03-31 | $17.99 | $3.53 | x |
| 2009-03-31 | $13.47 | $3.53 | x |
| 2010-03-31 | $13.89 | $3.53 | x |
| 2011-03-31 | $10.38 | $3.53 | x |
| 2012-03-31 | $8.16 | $3.53 | x |
| 2013-03-31 | $5.17 | $3.53 | x |
| 2014-03-31 | $10.10 | $3.53 | x |
| 2015-03-31 | $0.60 | $3.53 | x |
| 2016-03-31 | $5.34 | $3.53 | x |
| 2017-03-31 | $94.49 | $3.53 | x |
| 2018-03-31 | $396.91 | $3.53 | x |
| 2019-03-31 | $549.12 | $3.53 | x |
| 2020-03-31 | $221.03 | $3.53 | x |
| 2021-03-31 | $120.34 | $3.53 | x |
| 2022-03-31 | $22.83 | $3.53 | x |
| 2023-03-31 | $15.20 | $3.53 | x |
| 2024-03-31 | $10.94 | $3.53 | x |
| 2025-03-31 | $10.11 | $3.53 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aurora Cannabis Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.28%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.46%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 1.50x
- Recent ROE (0.28%) is above the historical average (-64.91%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 0.08% | 0.00% | 0.00x | 1.00x | $-167.01K |
| 2008 | -10.54% | -340.87% | 0.03x | 1.00x | $-345.57K |
| 2009 | -9.01% | -356.71% | 0.03x | 1.01x | $-307.26K |
| 2010 | -2.57% | 0.00% | 0.00x | 1.01x | $-215.08K |
| 2011 | -23.47% | 0.00% | 0.00x | 1.01x | $-459.91K |
| 2012 | -29.24% | 0.00% | 0.00x | 1.07x | $-423.77K |
| 2013 | -57.00% | 0.00% | 0.00x | 1.04x | $-462.52K |
| 2014 | -29.41% | 0.00% | 0.00x | 1.39x | $-535.60K |
| 2015 | -248.34% | 0.00% | 0.00x | 3.53x | $-9.90 Million |
| 2016 | -99.73% | -397.71% | 0.08x | 3.19x | $-6.30 Million |
| 2017 | -5.90% | -71.78% | 0.06x | 1.47x | $-34.94 Million |
| 2018 | 4.61% | 130.33% | 0.03x | 1.22x | $-83.96 Million |
| 2019 | -6.67% | -119.54% | 0.04x | 1.28x | $-733.48 Million |
| 2020 | -153.50% | -1221.68% | 0.09x | 1.36x | $-3.50 Billion |
| 2021 | -34.08% | -282.82% | 0.09x | 1.34x | $-897.14 Million |
| 2022 | -350.05% | -776.02% | 0.24x | 1.89x | $-1.77 Billion |
| 2023 | -166.43% | -364.88% | 0.24x | 1.89x | $-865.69 Million |
| 2024 | -12.36% | -25.65% | 0.32x | 1.50x | $-125.40 Million |
| 2025 | 0.28% | 0.46% | 0.40x | 1.50x | $-54.80 Million |
Industry Comparison
This section compares Aurora Cannabis Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $383,263,385
- Average return on equity (ROE) among peers: -496.63%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aurora Cannabis Inc (ACB) | $567.83 Million | 0.08% | 0.37x | $199.15 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |